Gainers Genfit SA rose 47.5% to $4.90 in pre-market trading. Ipsen and GENFIT reported an exclusive licensing agreement for Elafibranor. Spruce Biosciences, Inc. rose 23% to $3.05 in pre-market ...
网页链接Gainers Genfit SA rose 47.5% to $4.90 in pre-market trading. Ipsen and GENFIT reported an exclusive licensing agreement for Elafibranor. Spruce Biosciences, Inc. rose 23% to $3.05 in pre-market ...
网页链接
精彩评论